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Multinucleated giant cells (MGC) have been observed in a variety of granulomatous conditions, 
including microbial infections (e.g., tuberculosis), foreign body reactions to implants (e.g., 
medical devices), foreign body reactions to inhaled particles (e.g., engineered nanomaterials), 
and disorders of unknown etiology (e.g., sarcoidosis). Generally, MGC are morphologically 
classified based on the number and arrangement of nuclei. The two major types of MGC are 
foreign body giant cells and Langhans giant cells. These MGC are formed by the fusion of 
macrophages, often in response to persistent, foreign microorganisms or materials. Although 
MGC are known to be associated with granulomas, their involvement in the development of 
these conditions has not been well described. This is in part due to a lack of well-characterized 
models of MGC populations. The objective of this study is to develop an in vitro model of 
macrophage fusion in order to study MGC function. Previous reports have shown that MGC 
formation is induced by interleukin-4 (IL-4). Therefore, we investigated a model of IL-4-induced 
fusion in murine bone marrow-derived macrophages (BMdM). As expected, IL-4 treatment 
resulted in increased percent fusion of BMdM. The formation of MGC was optimized by 
modification of culture conditions, including alteration of the growth surface and treatment with 
either macrophage colony-stimulating factor (M-CSF) or granulocyte-macrophage colony-
stimulating factor (GM-CSF). Ongoing studies involve identification of molecules that regulate 
MGC formation. An increased understanding of this mechanism will provide additional targets 
to control fusion. Further development of this controlled in vitro model will facilitate future 
investigation of MGC inflammatory activity and contribution to pathogenesis of granulomas. 
